iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionObjective Capital Management, LLC
Latest Disclosed Ownership1,815 shares
Latest Disclosed Value $ 306,463
Objective Capital Management, LLC ownership in 0JGB / iShares Trust - iShares Biotechnology ETF

On May 4, 2026 - Objective Capital Management, LLC filed a 13F-HR form disclosing ownership of 1,815 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $306,463 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 4, 2026 disclosing 1,815 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 0.00% during the quarter. The current value of the position is $237,856 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-04 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,815 0 0.00 306 0.00 0.3091
2026-02-04 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,815 0 0.00 306 16.79 0.3118
2025-10-30 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,815 0 0.00 262 14.41 0.2712
2025-08-14 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,815 -615 -25.31 230 -26.13 0.2579
2025-05-07 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,430 -30 -1.22 311 -4.62 0.3965
2025-03-18 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,460 -600 -19.61 325 -26.97 0.2173
2024-11-01 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,060 151 5.19 445 11.53 0.2617
2024-06-05 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,909 101 3.60 399 4.72 0.2695
2024-03-07 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,808 650 30.12 382 44.87 0.2908
2023-11-15 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,158 0 0.00 264 -3.66 0.2341
2023-08-15 2023-06-30 13F ISHARES BIOTECHNOLOGY ETF ISHARES BIOTECH 464287556 2,158 12 0.56 274 -1.44 0.2395
2023-05-12 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,146 38 1.80 277 0.36 0.2531
2023-02-27 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,108 0 0.00 277 11.74 0.2750
2022-11-14 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,108 0 0.00 247 -0.40 0.2634
2022-07-11 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,108 -1,071 -33.69 248 -40.10 0.2500
2022-04-20 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,179 1 0.03 414 -14.64 0.3181
2022-04-20 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,178 3,178 485 0.3430
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.